Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia ACompleted
NCT03061201Phase 2Updated Sep 30, 2025
Sponsor: Pfizer
Hemophilia A
United States
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy AdultsCompleted
NCT06237049Phase 2Updated Sep 30, 2025
Sponsor: Pfizer
Influenza, Human · SARS-CoV-2 Infection · COVID-19
United States
Ritlecitinib in Patients With Keloids or Those Undergoing KeloidectomyRecruiting
NCT06373458Phase 2Updated Sep 30, 2025
Sponsor: Icahn School of Medicine at Mount Sinai
Keloid
United States
Palbociclib After CDK and Endocrine Therapy (PACE)Active Not Recruiting
NCT03147287Phase 2Updated Sep 30, 2025
Sponsor: Dana-Farber Cancer Institute
Metastatic Breast Cancer
United States
Effect of the Inhibitors of the Way JAK-STAT on Regulatory B CellsTerminated
NCT03755297NAUpdated Sep 30, 2025
Sponsor: University Hospital, Montpellier
Rheumatoid Arthritis
France
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic DermatitisTerminated
NCT05250115N/AUpdated Sep 29, 2025
Sponsor: Pfizer
Dermatitis, Atopic
Germany
Goal-Directed Sedation in Mechanically Ventilated Infants and ChildrenRecruiting
NCT04801589Phase 3Updated Sep 29, 2025
Sponsor: Vanderbilt University Medical Center
Delirium · Critical Illness · Sedation Complication · Executive Dysfunction
United States
EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting SmokingCompleted
NCT03262662Phase 3Updated Sep 26, 2025
Sponsor: State University of New York at Buffalo
Tobacco Smoking
United States
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast CancerCompleted
NCT05501769Phase 1Updated Sep 26, 2025
Sponsor: Arvinas Estrogen Receptor, Inc.
Breast Cancer
United States, Spain
Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for SurgeryTerminated
NCT03535506Phase 2Updated Sep 26, 2025
Sponsor: Georgetown University
DCIS
United States
A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults.Completed
NCT06473519Phase 3Updated Sep 25, 2025
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
United States
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck CancerWithdrawn
NCT01326468NAUpdated Sep 25, 2025
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Head and Neck Cancer
A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult ParticipantsCompleted
NCT06712082Phase 1Updated Sep 25, 2025
Sponsor: Pfizer
Healthy
China
A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy AdultsCompleted
NCT06670170Phase 1Updated Sep 22, 2025
Sponsor: Pfizer
Healthy Volunteers
United States
TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial CarcinomaRecruiting
NCT04678362Phase 2Updated Sep 22, 2025
Sponsor: Centre Francois Baclesse
Urothelial Carcinoma
France
A Novel Mobile App & Population Management System to Manage Rheumatoid Arthritis FlaresCompleted
NCT02822521NAUpdated Sep 18, 2025
Sponsor: Brigham and Women's Hospital
Arthritis · Rheumatoid Arthritis
United States
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid LeukemiaActive Not Recruiting
NCT04258943Phase 1, Phase 2Updated Sep 18, 2025
Sponsor: Children's Oncology Group
Philadelphia Chromosome Positive CML · Accelerated Phase Chronic Myelogenous Leukemia · Blastic Phase Chronic Myelogenous Leukemia · Chronic Phase Chronic Myelogenous Leukemia
United States, France, Germany, Italy, Netherlands +3 more
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid TumorsTerminated
NCT06285097Phase 1Updated Sep 17, 2025
Sponsor: Pfizer
Neoplasms · Non-small-cell Lung Cancer · Melanoma · Squamous Cell Carcinoma of the Head and Neck
United States, Japan, Puerto Rico
NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)Completed
NCT03107988Phase 1Updated Sep 15, 2025
Sponsor: New Approaches to Neuroblastoma Therapy Consortium
Neuroblastoma
United States, Canada, France, United Kingdom
A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular DystrophyTerminated
NCT03362502Phase 1Updated Sep 15, 2025
Sponsor: Pfizer
Duchenne Muscular Dystrophy
United States
PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXEDCompleted
NCT06156215NAUpdated Sep 12, 2025
Sponsor: University of California, San Francisco
COVID-19
United States
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims DataCompleted
NCT06199934N/AUpdated Sep 10, 2025
Sponsor: Pfizer
SARS-CoV-2 · COVID-19 Vaccines
United States
A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy MenCompleted
NCT07015918Phase 1Updated Sep 10, 2025
Sponsor: Pfizer
Healthy Male Volunteers
Netherlands
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)Recruiting
NCT04385290Phase 1, Phase 2Updated Sep 8, 2025
Sponsor: Technische Universität Dresden
Acute Myeloid Leukemia
Germany
Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell LymphomaTerminated
NCT05626322Phase 1, Phase 2Updated Sep 5, 2025
Sponsor: Pfizer
Diffuse Large B-Cell Lymphoma
United States, Japan, South Korea

Previous page Next page